MCM2, RNASEH2A, and TOP2A expression level in cancer samples was significantly higher than noncancer samples (MCM2, P < 0.001, Figure 2(a); RNASEH2A, P < 0.001, Figure 2(b); TOP2A, P = 0.001, Figure 2(c)). This evidence concerns the gene RNASEH2A and cancer.